167 related articles for article (PubMed ID: 2450991)
1. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
[TBL] [Abstract][Full Text] [Related]
3. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
Peers C; Lang B; Newsom-Davis J; Wray DW
J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
Flink MT; Atchison WD
J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
[TBL] [Abstract][Full Text] [Related]
5. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
[TBL] [Abstract][Full Text] [Related]
6. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
Smith DO; Conklin MW; Jensen PJ; Atchison WD
J Physiol; 1995 Aug; 487(1):115-23. PubMed ID: 7473242
[TBL] [Abstract][Full Text] [Related]
7. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
Peers C; Johnston I; Lang B; Wray D
Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
[TBL] [Abstract][Full Text] [Related]
8. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
[TBL] [Abstract][Full Text] [Related]
9. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
Prior C; Lang B; Wray D; Newsom-Davis J
Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.
Roberts A; Perera S; Lang B; Vincent A; Newsom-Davis J
Nature; 1985 Oct 24-30; 317(6039):737-9. PubMed ID: 2414666
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
Flink MT; Atchison WD
J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells.
Magnelli V; Grassi C; Parlatore E; Sher E; Carbone E
FEBS Lett; 1996 May; 387(1):47-52. PubMed ID: 8654565
[TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum neurotoxin and Lambert-Eaton myasthenic syndrome IgG at mouse nerve terminals.
Lande S; Black J; Dolly JO; Lang B; Newsom-Davis J; W-Wray D
J Neural Transm Park Dis Dement Sect; 1989; 1(3):229-42. PubMed ID: 2550027
[TBL] [Abstract][Full Text] [Related]
14. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
Xu YF; Hewett SJ; Atchison WD
J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
[TBL] [Abstract][Full Text] [Related]
15. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
Lang B; Newsom-Davis J; Wray DW
Proc R Soc Lond B Biol Sci; 1988 Oct; 235(1278):103-10. PubMed ID: 2907138
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
17. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
18. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
[TBL] [Abstract][Full Text] [Related]
20. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
